7-148005600-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2383+27611A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.535 in 151,774 control chromosomes in the GnomAD database, including 22,196 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 22196 hom., cov: 30)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.337

Publications

10 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2383+27611A>G
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2383+27611A>G
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000627772.2
TSL:2
n.556+27611A>G
intron
N/A
CNTNAP2
ENST00000636870.1
TSL:5
n.2245+27611A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.535
AC:
81147
AN:
151656
Hom.:
22184
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.425
Gnomad AMI
AF:
0.584
Gnomad AMR
AF:
0.621
Gnomad ASJ
AF:
0.474
Gnomad EAS
AF:
0.585
Gnomad SAS
AF:
0.445
Gnomad FIN
AF:
0.661
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.569
Gnomad OTH
AF:
0.518
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.535
AC:
81188
AN:
151774
Hom.:
22196
Cov.:
30
AF XY:
0.539
AC XY:
39993
AN XY:
74168
show subpopulations
African (AFR)
AF:
0.425
AC:
17583
AN:
41370
American (AMR)
AF:
0.621
AC:
9472
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.474
AC:
1642
AN:
3466
East Asian (EAS)
AF:
0.585
AC:
3004
AN:
5134
South Asian (SAS)
AF:
0.445
AC:
2128
AN:
4786
European-Finnish (FIN)
AF:
0.661
AC:
6988
AN:
10564
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.569
AC:
38621
AN:
67902
Other (OTH)
AF:
0.515
AC:
1082
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1754
3509
5263
7018
8772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.532
Hom.:
14589
Bravo
AF:
0.532
Asia WGS
AF:
0.480
AC:
1668
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.6
DANN
Benign
0.80
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2214681; hg19: chr7-147702692; API